Date Sent: 01/06/2017 10:20 AM EST
Sender: Michigan Health Alert Network
Subject: Updated MDHHS Zika Virus Testing Guidance for Healthcare Providers, January 2017
The Michigan Department of Health and Human Services (MDHHS) has updated the guidance provided to Michigan Healthcare Providers regarding specimens that will be accepted for Zika virus testing at the MDHHS Bureau of Laboratories (BOL) in the attached Memo. You can also find a copy in the Alert Details section of MIHAN.
Over the past few months, capacity for Zika virus testing has improved. Some commercial laboratories are now offering assays for Zika virus PCR and IgM. Clinicians should be aware that there can be substantial antibody cross reactivity between flaviviruses (e.g., Zika, dengue, West Nile virus). Any positive or equivocal Zika IgM should be confirmed with additional testing, which at this time is only available through public health laboratories, including MDHHS BOL.
Michigan healthcare providers no longer need pre-approval from the local health department to submit specimens for Zika virus testing at MDHHS. However, patients must meet the MDHHS testing criteria and samples must be accompanied by the required MDHHS forms. Samples submitted to MDHHS BOL that do not meet testing criteria or lack required paperwork will not be tested. Additional information about Zika virus testing at MDHHS BOL can be found at www.michigan.gov/mdhhslab, under the "What's New" topic.
Zika virus is a reportable condition in Michigan (under “Arboviral” on the list posted at http://www.michigan.gov/documents/mdch/Reportable_Diseases_Michigan_by_Pathogen_478489_7.pdf). Any healthcare provider or laboratory must report suspect and confirmed cases of Zika virus to the appropriate Michigan local public health department.
Please share the attached Memo with hospitals, laboratories and healthcare providers in your jurisdiction.
This message was sent to the following roles: Communicable Disease, Epidemiology, Laboratory, Health Officer, Medical Director, Healthcare.